NHS to Roll Out 7-Minute Sponge on a String Test for Chronic Heartburn

Thousands of individuals suffering from chronic heartburn could soon be offered a revolutionary test at their local pharmacy to check for cancer. Known as the sponge on a string test, the procedure takes just seven minutes and can help detect oesophageal cancer early in people experiencing persistent acid reflux. The National Institute for Health and Care Excellence recommended the innovative test for use on the National Health Service to look for people with Barrett's oesophagus.

Barrett's oesophagus occurs when stomach acid damages the lining of the food pipe and over time, this can cause cells to grow abnormally, which increases the risk of oesophageal cancer. The sponge on a string test can be carried out in general practitioner surgeries, pharmacies and community diagnostic centres and is less invasive than an endoscopy, where a tube carrying a camera is passed down the throat. The test has already been used in a number of pilot schemes, but the recent guidance recommendation means it could be widely available on the National Health Service in England.

What Is the Sponge on a String Test and How Does It Work?

Draft guidance issued by the National Institute for Health and Care Excellence recommends two specific brands of the test, Cytosponge and EndoSign, for people with persistent gastro-oesophageal reflux disease, commonly known as acid reflux. Barrett's oesophagus is a precursor to oesophageal cancer and is caused by persistent reflux. The condition affects an estimated 1 to 2 per cent of adults and increases people's risk of oesophageal cancer.

Most people with Barrett's oesophagus, however, do not go on to develop the cancer, but the sponge on a string test offers a way to help monitor their condition. The test does not require sedation and works by patients swallowing a small capsule attached to a string, which dissolves in the stomach leaving a small sponge behind. The sponge is then pulled out via the string after a few minutes, collecting cells from the oesophageal lining for analysis in the laboratory.

Understanding Barrett's Oesophagus and Acid Reflux Risks

Barrett's oesophagus happens when the lower section of your food pipe or oesophagus is damaged by acid and bile coming back up from your stomach. Over time, the cells of the lining can be replaced by a different type of cell, similar to those that grow in your bowel. This can increase your risk of developing oesophageal cancer, but most people with Barrett's oesophagus do not get cancer. It affects up to two in every 100 people, and is more common in men. You can get it at any age, but most people diagnosed are over 50.

The condition is caused by long term reflux of acid or bile into your food pipe. When acid and bile come back up your oesophagus from your stomach, this is known as gastro-oesophageal reflux disease or acid reflux. Usually, stomach contents are kept in your stomach by a muscular valve. If you have Barrett's oesophagus, this valve may have become weak or moved out of place, allowing acid and bile from your stomach to leak upwards. Over time, the acid and bile cause the cells in the lower part of your oesophagus to become inflamed and damaged, eventually getting replaced by new cells that protect the lining from further damage.

Patient Preference and Expert Reactions to the New Guidance

The committee behind the guidance found that patients prefer the sponge on a string test to a traditional endoscopy. Commenting on the recommendation, Professor Jonathan Benger, chief executive of the National Institute for Health and Care Excellence, said, "Oesophageal cancer is very difficult to treat when it is diagnosed at a later stage, so identifying people sooner is really important." He added that capsule sponge tests offer a quick and less invasive way to detect concerning changes associated with oesophageal cancer or Barrett's oesophagus, helping to identify people who should go on to have further tests and treatment.

Professor Benger also noted that this new technology has the potential to make testing easier for patients, while helping the National Health Service focus valuable endoscopy capacity on those who need it most. Meanwhile, Professor Peter Johnson, national clinical director for cancer at National Health Service England, stated, "Thousands have already benefited from this incredibly efficient test through pilots we have been running, so it's fantastic it is now being considered for rollout across the country." Officials noted that people who receive an all clear sponge test result should still be monitored in the long term, and anyone whose results suggest they have Barrett's oesophagus or cancer would still need an endoscopy to further investigate and confirm these findings.

Next Steps for the National Health Service Rollout

A consultation on the draft guidance will now run until December 7 and final guidance can be expected in February 2027. If confirmed, the National Health Service will be required to begin introducing the technology, along with offering specialist staff training, for eligible patients where it is considered the most suitable option. More than 9,000 people are diagnosed with oesophageal cancer in the United Kingdom every year. While it is not clear what causes the cancer, having long term severe acid reflux or Barrett's oesophagus can increase people's risk.

Oesophageal cancer can be hard to spot, but symptoms include having problems swallowing, heartburn or acid reflux and symptoms of indigestion. Oesophageal cancer affects 9,400 people in the United Kingdom every year, and most people are over the age of 60. Smoking increases your risk of the disease, as does being overweight, drinking alcohol and having conditions like Barrett's oesophagus, where the cells lining your oesophagus have become abnormal. Only 12 per cent of patients survive for 10 or more years after being diagnosed, with around 8,000 oesophageal cancer deaths in the United Kingdom every year, equating to 22 every day.

Recognising the Warning Signs and Symptoms

Early diagnosis is key, so recognising the symptoms is vital. The most common warning signs include difficulty swallowing, unexplained weight loss, indigestion or heartburn that does not go away, and pain in the throat or behind the breastbone. But some people also experience a cough, hoarseness, dark poo, tiredness and food coming back up after swallowing. Monitoring these symptoms alongside new community testing initiatives aims to catch cases much earlier than previously possible.